{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T18:30:10Z","timestamp":1770229810680,"version":"3.49.0"},"reference-count":28,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NHS England\/Department of Health and Social Care"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNS"],"abstract":"<jats:p>The project aimed to gather, analyse, and compare the views of stakeholders about the proposed UK cystic fibrosis (CF) screening protocol incorporating next generation sequencing (NGS). The study design was based on principles of Q-methodology with a willingness-to-pay exercise. Participants were recruited from 12 CF centres in the UK. The study contained twenty-eight adults who have experience with CF (parents of children with CF (n = 21), including parents of children with CF transmembrane conductance regulator (CFTR)-related metabolic syndrome (CRMS)\/CF screen positive\u2014inconclusive diagnosis (CFSPID), an uncertain outcome (n = 3), and adults with CF (n = 4)), and nine health professionals involved in caring for children with CF. Parents and health professionals expressed a preference for a sensitive approach to NGS. This was influenced by the importance participants placed on not missing any children with CF via screening and the balance of harm between missing a case of CF compared to picking up more children with an uncertain outcome (CRMS\/CFSPID). Given the preference for a sensitive approach, the need for adequate explanations about potential outcomes including uncertainty (CFSPID) at the time of screening was emphasized. More research is needed to inform definitive guidelines for managing children with an uncertain outcome following CF screening.<\/jats:p>","DOI":"10.3390\/ijns10010013","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T11:18:46Z","timestamp":1707909526000},"page":"13","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Stakeholder Views of the Proposed Introduction of Next Generation Sequencing into the Cystic Fibrosis Screening Protocol in England"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1036-978X","authenticated-orcid":false,"given":"Pru","family":"Holder","sequence":"first","affiliation":[{"name":"Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care, King\u2019s College London, London SE5 9PJ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1077-9383","authenticated-orcid":false,"given":"Corinna C.","family":"Clark","sequence":"additional","affiliation":[{"name":"Warwick Medical School, Warwick University, Coventry CV4 7AL, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2326-4124","authenticated-orcid":false,"given":"Louise","family":"Moody","sequence":"additional","affiliation":[{"name":"Centre for Arts, Memory and Communities, Coventry University, Coventry CV1 5FB, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3268-6276","authenticated-orcid":false,"given":"Felicity K.","family":"Boardman","sequence":"additional","affiliation":[{"name":"Warwick Medical School, Warwick University, Coventry CV4 7AL, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqui","family":"Cowlard","sequence":"additional","affiliation":[{"name":"Paediatric Respiratory Medicine, Royal London Children\u2019s Hospital, London E1 1FR, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorna","family":"Allen","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis Trust, London EC3N 1RE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Walter","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis Trust, London EC3N 1RE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9485-6754","authenticated-orcid":false,"given":"James R.","family":"Bonham","sequence":"additional","affiliation":[{"name":"Pharmacy, Diagnostics and Genetics, Sheffield Children\u2019s NHS Foundation Trust, Sheffield S10 2TH, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7334-8708","authenticated-orcid":false,"given":"Jane","family":"Chudleigh","sequence":"additional","affiliation":[{"name":"Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care, King\u2019s College London, London SE5 9PJ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,14]]},"reference":[{"key":"ref_1","unstructured":"NHS England (2022). Cystic Fibrosis Screening Laboratory Handbook, NHSE."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcf.2020.11.006","article-title":"Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome\/cystic fibrosis screen positive, inconclusive diagnosis (CRMS\/CFSPID)","volume":"20","author":"Barben","year":"2021","journal-title":"J. Cyst. Fibros. Off. J. Eur. Cyst. Fibros. Soc."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Bergougnoux, A., Lopez, M., and Girodon, E. (2020). The Role of Extended CFTR Gene Sequencing in Newborn Screening for Cystic Fibrosis. Int. J. Neonatal Screen., 6.","DOI":"10.3390\/ijns6010023"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"114972","DOI":"10.1016\/j.socscimed.2022.114972","article-title":"\u2018We\u2019re kind of like genetic nomads\u2019: Parents\u2019 experiences of biographical disruption and uncertainty following in\/conclusive results from newborn cystic fibrosis screening","volume":"301","author":"Boardman","year":"2022","journal-title":"Soc. Sci. Med."},{"key":"ref_5","unstructured":"Charmaz, K. (2006). Constructing Grounded Theory A Practical Guide Through Qualitative Analysis, Sage."},{"key":"ref_6","unstructured":"Charmaz, K. (2014). Constructing Grounded Theory, Sage. [2nd ed.]."},{"key":"ref_7","unstructured":"Cystic Fibrosis Trust (2023). UK Cystic Fibrosis Registry 2022 Annual Data Report, Cystic Fibrosis Trust."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e037081","DOI":"10.1136\/bmjopen-2020-037081","article-title":"Qualitative exploration of health professionals\u2019 experiences of communicating positive newborn bloodspot screening results for nine conditions in England","volume":"10","author":"Chudleigh","year":"2020","journal-title":"BMJ Open"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e044755","DOI":"10.1136\/bmjopen-2020-044755","article-title":"Processing of positive newborn screening results: A qualitative exploration of current practice in England","volume":"10","author":"Chudleigh","year":"2020","journal-title":"BMJ Open"},{"key":"ref_10","unstructured":"Clark, C., Holder, P., Boardman, F., Moody, L., Cowlard, J., Allen, L., Walter, C., Bohnam, J., and Chudleigh, J. (2024). International Perspectives of Extended Genetic Sequencing When Used as Part of Newborn Screening to Identify Cystic Fibrosis, Warwick University. (Submitted)."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Kinsella, S., Hopkins, H., Cooper, L., and Bonham, J.R. (2022). A Public Dialogue to Inform the Use of Wider Genomic Testing When Used as Part of Newborn Screening to Identify Cystic Fibrosis. Int. J. Neonatal. Screen., 8.","DOI":"10.3390\/ijns8020032"},{"key":"ref_12","first-page":"1349","article-title":"Presenting life with cystic fibrosis: A Q-methodological approach to developing balanced, experience-based prenatal screening information","volume":"18","author":"Wright","year":"2015","journal-title":"Health Expect. Int. J. Public Particip. Health Care Health Policy"},{"key":"ref_13","unstructured":"Chudleigh, J., Holder, P., Clark, C., Moody, L., Cowlard, J., Allen, L., Walter, C., Bohnam, J., and Boardman, F. (2024). Parents\u2019 Views of Wider Genomic Testing When Used as Part of Newborn Screening to Identify Cystic Fibrosis, Warwick University. (Submitted)."},{"key":"ref_14","unstructured":"Westendorp Van, P.H. (1976, January 5\u20139). NSS Price Sensitivity Meter (PSM)\u2014A New Approach to Study Consumer-Perception of Prices. Proceedings of the 29th ESOMAR Congress, Amsterdam, The Netherlands."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Braun, V., and Clarke, V. (2021). Thematic Analysis: A Practical Guide, Sage.","DOI":"10.1007\/978-3-319-69909-7_3470-2"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3310\/HTXH9624","article-title":"Co-designed strategies for delivery of positive newborn bloodspot screening results to parents: The ReSPoND mixed-methods study","volume":"10","author":"Chudleigh","year":"2022","journal-title":"Health Soc. Care Deliv. Res."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Castaldo, A., Cimbalo, C., Castaldo, R.J., D\u2019Antonio, M., Scorza, M., Salvadori, L., Sepe, A., Raia, V., and Tosco, A. (2020). Cystic Fibrosis-Screening Positive Inconclusive Diagnosis: Newborn Screening and Long-Term Follow-Up Permits to Early Identify Patients with CFTR-Related Disorders. Diagnostics, 10.","DOI":"10.3390\/diagnostics10080570"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ooi, C.Y., Sutherland, R., Castellani, C., Keenan, K., Boland, M., Reisman, J., Bjornson, C., Chilvers, M.A., van Wylick, R., and Kent, S. (2019). Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis. BMC Pediatr., 19.","DOI":"10.1186\/s12887-019-1756-4"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/thoraxjnl-2012-201747","article-title":"Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening","volume":"67","author":"Hoo","year":"2012","journal-title":"Thorax"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1700326","DOI":"10.1183\/13993003.00326-2017","article-title":"Pulmonary function deficits in newborn screened infants with cystic fibrosis managed with standard UK care are mild and transient","volume":"50","author":"Davies","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.jpeds.2005.08.011","article-title":"Delayed Diagnosis of Cystic Fibrosis and the Family Perspective","volume":"147","author":"Kharrazi","year":"2005","journal-title":"J. Pediatr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1513\/AnnalsATS.201806-432ED","article-title":"Diagnosing Cystic Fibrosis in Adults: Better Late Than Never","volume":"15","author":"Jain","year":"2018","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Terlizzi, V., Padoan, R., Claut, L., Colombo, C., Fabrizzi, B., Lucarelli, M., Bruno, S.M., Castaldo, A., Bonomi, P., and Taccetti, G. (2020). CRMS\/CFSPID Subjects Carrying D1152H CFTR Variant: Can the Second Variant Be a Predictor of Disease Development?. Diagnostics, 10.","DOI":"10.3390\/diagnostics10121080"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/cge.12711","article-title":"Refining the continuum of CFTR-associated disorders in the era of newborn screening","volume":"89","author":"Levy","year":"2016","journal-title":"Clin. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jcf.2021.03.015","article-title":"A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS\/CFSPID) in six Italian centres","volume":"20","author":"Terlizzi","year":"2021","journal-title":"J. Cyst. Fibros. Off. J. Eur. Cyst. Fibros. Soc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/ppul.21475","article-title":"Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome","volume":"46","author":"Ren","year":"2011","journal-title":"Pediatr. Pulmonol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e1377","DOI":"10.1542\/peds.2014-2081","article-title":"Inconclusive diagnosis of cystic fibrosis after newborn screening","volume":"135","author":"Ooi","year":"2015","journal-title":"Pediatrics"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"E103","DOI":"10.1002\/ppul.22918","article-title":"Diagnosis of cystic fibrosis in the kindred of an infant with CFTR-related metabolic syndrome: Importance of follow-up that includes monitoring sweat chloride concentrations over time","volume":"49","author":"Williams","year":"2014","journal-title":"Pediatr. Pulmonol."}],"container-title":["International Journal of Neonatal Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2409-515X\/10\/1\/13\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:59:49Z","timestamp":1760104789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2409-515X\/10\/1\/13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,14]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["ijns10010013"],"URL":"https:\/\/doi.org\/10.3390\/ijns10010013","relation":{},"ISSN":["2409-515X"],"issn-type":[{"value":"2409-515X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,14]]}}}